Cargando…

PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE

Detalles Bibliográficos
Autores principales: Meunier, Benoit, Manceau, Sandra, Corsia, Alice, Ihlem, Rahal, Jestin, Mathhieu, Verheyden, Laetitia, Lefrère, François, Cavazzana, Marina, Arlet, Jean-Benoît, Joseph, Laure
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428854/
http://dx.doi.org/10.1097/01.HS9.0000976756.95685.44
_version_ 1785090570022027264
author Meunier, Benoit
Manceau, Sandra
Corsia, Alice
Ihlem, Rahal
Jestin, Mathhieu
Verheyden, Laetitia
Lefrère, François
Cavazzana, Marina
Arlet, Jean-Benoît
Joseph, Laure
author_facet Meunier, Benoit
Manceau, Sandra
Corsia, Alice
Ihlem, Rahal
Jestin, Mathhieu
Verheyden, Laetitia
Lefrère, François
Cavazzana, Marina
Arlet, Jean-Benoît
Joseph, Laure
author_sort Meunier, Benoit
collection PubMed
description
format Online
Article
Text
id pubmed-10428854
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104288542023-08-17 PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE Meunier, Benoit Manceau, Sandra Corsia, Alice Ihlem, Rahal Jestin, Mathhieu Verheyden, Laetitia Lefrère, François Cavazzana, Marina Arlet, Jean-Benoît Joseph, Laure Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428854/ http://dx.doi.org/10.1097/01.HS9.0000976756.95685.44 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Meunier, Benoit
Manceau, Sandra
Corsia, Alice
Ihlem, Rahal
Jestin, Mathhieu
Verheyden, Laetitia
Lefrère, François
Cavazzana, Marina
Arlet, Jean-Benoît
Joseph, Laure
PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE
title PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE
title_full PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE
title_fullStr PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE
title_full_unstemmed PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE
title_short PB2514: IMMUNOGENICITY OF ANTI-SARS-COV-2 VACCINES IN PATIENTS WITH SEVERE SICKLE CELL DISEASE
title_sort pb2514: immunogenicity of anti-sars-cov-2 vaccines in patients with severe sickle cell disease
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428854/
http://dx.doi.org/10.1097/01.HS9.0000976756.95685.44
work_keys_str_mv AT meunierbenoit pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease
AT manceausandra pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease
AT corsiaalice pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease
AT ihlemrahal pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease
AT jestinmathhieu pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease
AT verheydenlaetitia pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease
AT lefrerefrancois pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease
AT cavazzanamarina pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease
AT arletjeanbenoit pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease
AT josephlaure pb2514immunogenicityofantisarscov2vaccinesinpatientswithseveresicklecelldisease